These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18036256)

  • 21. CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy.
    Benito JM; López M; Lozano S; Martinez P; González-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):227-33. PubMed ID: 15018711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of activation marker and TCR V beta gene product expression by CD4+ and CD8+ T cells in peripheral blood and lymph nodes from HIV-infected patients.
    Ramzaoui S; Jouen-Beades F; Michot F; Borsa-Lebas F; Humbert G; Tron F
    Clin Exp Immunol; 1995 Feb; 99(2):182-8. PubMed ID: 7851009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation.
    Cohen Stuart JW; Hazebergh MD; Hamann D; Otto SA; Borleffs JC; Miedema F; Boucher CA; de Boer RJ
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):203-11. PubMed ID: 11115950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
    Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy.
    Lim A; French MA; Price P
    J Acquir Immune Defic Syndr; 2009 Jul; 51(3):248-57. PubMed ID: 19363449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease.
    Meng Q; Sayin I; Canaday DH; Mayanja-Kizza H; Baseke J; Toossi Z
    PLoS One; 2016; 11(11):e0166954. PubMed ID: 27870882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.
    Resino S; Navarro J; Bellón JM; Gurbindo D; León JA; Muñoz-Fernández MA
    Clin Exp Immunol; 2001 Aug; 125(2):266-73. PubMed ID: 11529919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
    Almeida M; Cordero M; Almeida J; Orfao A
    Cytometry B Clin Cytom; 2007 Jan; 72(1):22-33. PubMed ID: 17051525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4(+) T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy.
    Resino S; Seoane E; Gutiérrez MD; León JA; Muñoz-Fernández MA
    J Acquir Immune Defic Syndr; 2006 Jul; 42(3):269-76. PubMed ID: 16810122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regeneration and tolerance factor: a correlate of human immunodeficiency virus-associated T-cell activation.
    Givens TS; DuChateau BK; Boomer JS; Westerman MP; Gilman-Sachs A; Beaman KD
    Clin Diagn Lab Immunol; 1999 Nov; 6(6):872-7. PubMed ID: 10548579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of CD4+CD8+ double positive T-lymphocyte phenotype and function in Indian patients infected with HIV-1.
    Chauhan NK; Vajpayee M; Mojumdar K; Singh R; Singh A
    J Med Virol; 2012 Jun; 84(6):845-56. PubMed ID: 22499005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
    Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
    Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.
    Paul ME; Shearer WT; Kozinetz CA; Lewis DE
    J Allergy Clin Immunol; 2001 Aug; 108(2):258-64. PubMed ID: 11496243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation.
    Benito JM; Lopez M; Lozano S; Ballesteros C; Capa L; Martinez P; Gonzalez-Lahoz J; Soriano V
    J Infect Dis; 2005 Dec; 192(12):2142-6. PubMed ID: 16288380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.
    Resino S; Abad ML; Navarro J; Bellón JM; Sánchez-Ramón S; Angeles Muñoz-Fernández M
    Clin Exp Immunol; 2003 Jan; 131(1):130-7. PubMed ID: 12519396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
    Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
    J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.